Sudden cardiac death: the role of risk stratification
S Luke Kusmirek1, Michael R Gold
1Medical University of South Carolina, Charleston, SC 29425, USA.
Insights
Sudden cardiac death remains a significant health concern. Microvolt T wave alternans shows promise for improving risk assessment in patients, potentially enhancing implantable cardioverter defibrillator (ICD) therapy selection.
Area of Science:
- Cardiology
- Medical Technology
Background:
- Sudden cardiac death (SCD) causes ~400,000 US deaths annually.
- Current implantable cardioverter defibrillator (ICD) selection methods are imperfect, leaving high-risk patients unprotected and many receiving unnecessary ICDs.
- Existing therapies for SCD are expensive and carry risks.
Purpose of the Study:
- To review current noninvasive and invasive tests for sudden cardiac death risk assessment.
- To highlight the diagnostic value of microvolt T wave alternans (MTWA) in identifying patients at risk for SCD.
Main Methods:
- Review of existing literature on sudden cardiac death risk stratification.
- Analysis of the performance of various diagnostic tests, including invasive and noninvasive methods.
- Emphasis on the clinical utility and emerging role of microvolt T wave alternans.
Main Results:
- Current risk assessment strategies for implantable cardioverter defibrillators (ICDs) have limitations.
- Microvolt T wave alternans is an increasingly recognized and valuable tool for predicting sudden cardiac death risk.
- Improved patient selection for ICD therapy is needed to optimize outcomes.
Conclusions:
- More accurate methods are needed to identify patients at high risk of sudden cardiac death.
- Microvolt T wave alternans offers a promising noninvasive approach to improve risk stratification.
- Optimizing implantable cardioverter defibrillator (ICD) therapy selection can reduce mortality and healthcare costs.
Abstract:
Sudden cardiac death syndrome remains a major health problem responsible for approximately 400,000 deaths annually in the US. Effective therapies exist but are costly and are associated with potential complications. Currently used strategies for selection of the best candidates for implantable cardioverter defibrillator (ICD) therapy are imperfect and leave a large number of high-risk patients unprotected. At the same time, many patients who received ICDs will never develop tachyarrhythmia and require ICD intervention. The article summarizes the current status and applicability of the noninvasive and invasive tests used for sudden cardiac death risk assessment with the emphasis on the increasingly recognized value of microvolt T wave alternans.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Introduction Cardiac Emergencies
Acute Coronary Syndrome I: Introduction
Cardiomyopathy I: Introduction and Classification
